Pharma Construct
ActiveSummary
Pharma Construct has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,975) and a net result of -€983. Equity is shrinking by about 117% per year across the filed financial years. Its solvency ranks better than 5% of 4,274 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
24-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
19-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Weakest financial yearnet -€1,996
Net result drops to -€1,996, the lowest in the series; recovery starts the following year.
07-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.